Drugs / SAR428926
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02575781 | Oct 2015 → Jun 2018 | cancer | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAR428926 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02575781 ↗ |
| Route | Intravenous | “administered intravenously” NCT02575781 ↗ |